BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Fenofibrate
,
rs2230926
,
BRAF
,
glucose metabolic process
,
Ischemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
esophageal adenocarcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
Barrett's esophageal tissues and esophageal adenocarcinoma specimens
ARID1A knockdown in OE33 esophageal adenocarcinoma cells
Esophageal adenocarcinoma OE33 cells overexpressing miR-223
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma
Esophageal adenocarcinoma and Barrett's esophagus global gene expression signatures
Explore Curated Studies Results
Literature
Most Relevant Literature
AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gas…
Early Barrett esophagus-related neoplasia in segments 1 cm or longer is always associated with intes…
Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.
Elevated Z line: a new sign of Barrett's esophagus on double-contrast barium esophagograms.
Primary adenocarcinoma of the upper esophagus: A rare presentation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ